University of Patras
Μελέτη των πλειοτροπικών δράσεων της απολιποπρωτεΐνης C3 με στόχο την ανάδειξη καινοτόμων φαρμακολογικών παρεμβάσεων που στοχεύουν στη λειτουργικότητα της HDL
Abstract
dc:descriptionApolipoprotein C3 (APOC3) is mainly synthesized in the liver and intestine and its size is 8.8 kDa. It is predominantly distributed to lipoproteins characterized by high levels of apolipoprotein B (APOB-lipoproteins), such as chylomicrons, VLDL, IDL and LDL and approximately half of plasma APOC3 associates with HDL. Although there was a predominant view that APOC3 associates with HDL by simple binding to pre-existing particles, recent data support that biogenesis of APOC3-containing HDL (APOC3-HDL) requires Abca1. Moreover, APOC3-HDL contributes to plasma triglyceride homeostasis, by preventing APOC3 association with triglyceride-rich lipoproteins.Interestingly, APOC3-HDL also shows positive correlation with the morbidly obese phenotype. However, the roles of APOC3 in HDL functionality and adipose tissue metabolic activity remain unknown. In a clinical trial of morbidly obese subjects, we observed significant levels of APOC3-HDL particles in plasma immediately prior bariatric surgery, while six months after operation all HDL was mainly APOA1-HDL with only trace amounts of APOC3-HDL being present. This change in apolipoprotein content of HDL was associated with alterations in the antioxidant properties of HDL and plasma enzymatic activities of lecithin cholesterol acyltransferase (LCAT) and cholesterylester transfer protein (CETP). These clinical observations supported the interesting hypothesis that changes in APOC3 content of HDL associate with alterations in HDL particle functionality and overall body energy metabolism. To this date most of the studies have focused on the unique, broadly accepted, functional role of APOC3 in atherosclerosis, and more specifically in regulating plasma triglyceride levels by inhibiting Lpl activity and catabolism of triglyceride-rich lipoproteins. Based on this function, Apoc3 antisense oligonucelotides are currently in clinical trials for the treatment of hypertriglyceridemia. However, the roles of APOC3 in the function of HDL and metabolic activity of the adipose tissue remain unknown. Therefore, in the present study we investigated the direct effects of APOC3 expression on the structure and function of HDL, as well as on the metabolic activity of white (WAT) and brown adipose tissue (BAT).For this purpose C57BL/6 mice were infected with an adenovirus expressing human APOC3 or a control adenovirus AdGFP and five days post-infection blood and tissue samples were collected. HDL was then isolated and analyzed for its apolipoprotein and lipid content as well as for the structure and functionality of its particles. In addition, serum metabolomic analysis was performed by NMR and purified mitochondria from BAT and WAT were analyzed for Ucp1, Cytc and Cox4 protein levels as an indirect measure of their metabolic activity.Combined, our data show that APOC3 alters the apolipoprotein content of HDL, which in turn modulates its lipidome, resulting in significant changes in the structure and functionality of HDL. Apart from the effect of APOC3 on HDL, this apolipoprotein has a major effect on energy metabolism by activating the metabolic activity selectively in BAT.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zvintzou, Evangelia
- Ζβίντζου, Ευαγγελία
Subjects
dc:subject × 10Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42666